a method for inhibiting neoplasia , particularly cancerous and precancerous lesions by exposing the affected cells to amino or pyridylamino cyclobutane derivatives .
particularly useful compounds in the practice of the methods of this invention include : compounds of the formula ( 1 ) may form pharmaceutically acceptable salts with acids such as hydrochloric , hydrobromic , sulphuric and phosphoric acids .
